The Kursaal Bern, a traditional Swiss company with the three business segments congress center, hotel & gastronomy and casino, successfully launched the first initial public offering since the outbreak of the pandemic on the BX Swiss on June 29, 2021. Kellerhals
Molecular Partners, a clinical-stage biotech company, announced the pricing of its Initial Public Offering of 3,000,000 American Depositary Shares (ADS) in the United States at a public offering price of USD 21.25 per ADS, for total gross proceeds of approximately
the Swiss team consisted mainly of Matthias Courvoisier (pictured left), Yves Mauchle (pictured right) and Beau Visser
Sorry, the comment form is closed at this time.
